Bioactivity:

Gypenoside L inhibits autophagic flux and induces cell death in human esophageal cancer cells through endoplasm reticulum stress-mediated Ca2+ release. It also inhibit non-small cell lung carcinoma A549 cell inhibitory activity.

CAS nr:

94987-09-4

Purity:

98%

Molecular Weight:

801

SMILES:

C/C(C)=C\CC[C@](C)(O)[C@H]6CC[C@]5(C)[C@@H]6[C@H](O)C[C@H]4[C@@]5(C)CC[C@H]3C(C)(C)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)C[C@@]34C

Formula:

C42H72O14

Pathway:

Immunology/Inflammation,NF-_b,MAPK,Membrane transporter/Ion channel,MAPK,Metabolism

Target:

ROS,NF-_B,p38 MAPK,Calcium Channel,ERK,Calcium Channel